Health Professions, General Medicine, Internal Medicine
59
Scopus Publications
Scopus Publications
Thiamine supplementation in the management of diabetic ketoacidosis: An open-label, randomized controlled trial Alisha Khan, Shiva Narang, Amitesh Aggarwal, Nishant Raizada Endocrine and Metabolic Science, 2026 Background Diabetic ketoacidosis (DKA) is an acute complication of diabetes mellitus with significant mortality. Emerging evidence suggests a potential role for thiamine, as an adjuvant therapy in DKA management. This study explored the effect of thiamine supplementation on the resolution of DKA. Methods An open-label, randomized controlled trial was conducted at a tertiary care facility. Sixty adult DKA patients were randomized into two groups, using online randomization generator. Thirty patients (intervention group) received thiamine supplementation with standard DKA therapy, and thirty patients (active control group) received only standard DKA therapy. Baseline investigations were performed and statistical analyses were conducted to compare time to resolution of ketoacidosis, morbidity, mortality, and adverse events between the two groups. Results The study showed no significant difference between the demographic, clinical and laboratory parameters within the two groups. In the intervention vs the active control group, time to resolution of DKA (9.6 vs. 9.9 h, p = 0.342), duration of hospital stays (4.2 vs. 3.7 days, p = 0.157), and complications (20 % vs. 10 %, p = 0.472) showed no significant statistical differences. Infections (41.7 %) and non-compliance (38.3 %) were leading causes for precipitation of DKA. No adverse events were observed. Conclusion There was no statistically significant difference between the two study groups. Given the safety profile, easy availability and cost effectiveness of thiamine, further research is warranted in larger cohorts to validate the potential therapeutic role of thiamine as adjuvant in DKA management.
Abnormalities of Endocrine Function Tests in COVID‑19‑Recovered Individuals Phibakordor L. Nonglait, Srivenkata Madhu, Nishant Raizada, Amitesh Aggarwal, Rafat Ahmed, Mohammad Aslam Indian Journal of Endocrinology and Metabolism, 2025 Introduction: Impact of COVID-19 on endocrine system due to the widespread distribution of Angiotensin Converting Enzyme-2 (ACE2) receptors in different endocrine organs of the body has been shown in several studies. However, most of these studies were in the setting of acute COVID-19. The present study was planned to comprehensively evaluate endocrine abnormalities in COVID-19-recovered individuals. Methods: Eighty-three COVID-19-recovered individuals were recruited 8-20 weeks following the recovery. They were further stratified according to disease severity as defined by the Indian Council of Medical Research (ICMR). After recording their demographic and clinical details, an evaluation of inflammatory markers and different hypothalamic-pituitary axes involving thyroid, adrenal, gonadal and prolactin axes was carried out in them. Those who were on treatment for a previous endocrine disorder were not included in the study. Results: Eighty-three patients [33 (39.7%): mild and 50 (60.3%): moderate to severe COVID-19] were recruited after a period of 14.7 ± 3.4 weeks after recovery. Forty-four patients (53%) had some form of endocrine dysfunction. Central pituitary axis dysfunction was observed in 28 patients (33.7%), of which alterations in prolactin (20.4%) were the most common. Thyroid function abnormalities were noted in 25 (30.1%) patients, while gonadal dysfunction was detected in 14% of males and 6% of reproductive-aged females, respectively. Conclusion: Endocrine function test abnormalities were seen in a significant proportion of individuals even after a mean period of more than 3 months post-recovery from COVID-19. These have implications for the long-term endocrine and metabolic health of COVID-19-recovered individuals, besides alerting physicians to interpret endocrine function tests with caution after recovery from acute COVID-19 illness.
Position statement on hypertension by Indian Society of Hypertension, 2023 Anuj Maheshwari, Rajeev Gupta, Narsingh Verma, S. N. Narasingan, Ram B. Singh, Banshi Saboo, C. H. Vasanth Kumar, Arvind Gupta, Manoj K. Srivastava, Amit Gupta, Saurabh Srivastava, Amitesh Aggarwal, Ajoy Tewari, Sajid Ansari, Bijay Patni, Dinesh Agarwal, G. B. Sattur, Lily Rodrigues, K. K. Pareek, Murar Yeolekar, Samar Banerjee, L. Sreenivasamurthy, M. K. Das, Shashank Joshi, Shailendra Vajpeyee, V. V. Muthusamy, A. Muruganathan Journal of Human Hypertension, 2024
Impact of BCG Vaccination on Morbidity and Mortality among Adult Patients with Tuberculous Meningitis: A Prospective Cohort Analysis Journal Indian Academy of Clinical Medicine, 2024
May Measurement Month 2021: an analysis of blood pressure screening campaign results from India Anuj Maheshwari, Narsingh Verma, Jalees Fatima, Ajoy Tewari, Jothydev Kesavdev, Preeti Singh Dhoat, Amrit Kaur, Amit Gupta, Saurabh Srivastava, Abhinav Verma, Shivangi Maheshwari, Sajid Ansari, Amitesh Aggarwal, Abhishek Srivastava, Vanshika Arora, Thomas Beaney, Jonathan Clarke, Neil R Poulter European Heart Journal Supplement, 2024 Raised blood pressure (BP) is the leading preventable risk factor for cardiovascular diseases that makes a major impact on early mortality and morbidity. Recognizing hypertension in the community, educating people about routine BP monitoring, and improving medication compliance are all important steps in detecting, controlling, and managing hypertension. During the course of 5 months, members of the Indian Society of Hypertension organized unique medical indoor and outdoor camps at 100 screening locations around India for the May Measurement Month (MMM) 2021 study. At every location, BP was measured three times, and a questionnaire was completed. Participants known to have hypertension before the study whether taking or not taking treatment were not included (not a normal pre-requisite for exclusion in MMM). The analysis included 15 045 participants in total. After calculating the average of the second and third BP measurements, 16.4% of participants were found to have hypertension based on ≥140/90 mmHg thresholds (2461 out of 15 045). 14.0% of females and 16.4% of males had hypertension. 16.4% of participants had undiagnosed hypertension and were not receiving treatment. The MMM screening campaign has the potential for identifying large numbers of people with undiagnosed hypertension and raising awareness of the importance of raised BP among the general public, medical professionals, policymakers, the government, and the media. Future BP screening campaigns should be larger in scope and involve follow-ups with past participants.
Long-Term Persistence of COVID-Induced Hyperglycemia: A Cohort Study Vrinda Goel, Alpana Raizada, Amitesh Aggarwal, SV Madhu, Rajarshi Kar, Ananya Agrawal, Vikash Mahla, Ashish Goel American Journal of Tropical Medicine and Hygiene, 2024 Although the short-term mortality of patients with COVID-19 infection and hyperglycemia has been well documented, there is little available data regarding longer-term prognosis. The presence of diabetes has not only influenced disease severity but has also impacted its transmission dynamics. In this study, we followed a historical cohort of patients without previous history of diabetes who presented with moderate to severe COVID-19 and were found to have hyperglycemia (random blood glucose > 140 mg/dL) at the time of admission. We evaluated the need for antidiabetic therapy in these patients at the end of 6 months and the risk factors associated with persistent hyperglycemia determined by monthly values of self-monitored blood glucose. Of the seventy participants who were followed telephonically, 54 (77%) continued to receive antidiabetic therapy or have persistent hyperglycemia (> 140 mg/dL) at the end of 6 months. Persistent hyperglycemia at the end of follow-up, was found to be associated with a higher blood glucose at presentation.
Health Decline in Older Adults Journal of the Indian Medical Association, 2023
The increasing presence of the internet in the lives of patients and doctors: threat or opportunity? FNU Anamika, Ashish Goel, Amitesh Aggarwal, Ramansh Bandhu Gupta Indian Journal of Medical Ethics, 2023 The conventional sharing of information and education between doctor and patient is no longer what it used to be prior to Dr. Google’s entry into the mix with voluminous data, not only transforming but often threatening the patient-doctor relationship. While patients no longer seek basic information from their physicians since they’ve already consulted Dr. Google, the wise physician accepts that patients are now more aware, more involved in their own care, and more empowered with information. The good old doctor who knew everything is now more a myth that exists largely in folklore. While doctors may be well versed in a variety of fields, they have often narrowed down their areas of specialisation, while they continue to apply what they learn from their daily encounters with patients, establishing a stronger relationship over time. The challenge arises when a patient, having consulted Dr. Google, starts to question their doctor with the little knowledge gained from the internet. Biased opinions based on prior knowledge, have lately placed the doctor-patient relationship in jeopardy.
High level of psychological stress in COVID-19 recovered individuals: role of copeptin as a potential biomarker Phibakordor Lyngdoh Nonglait, Sri Venkata Madhu, Nishant Raizada, Amitesh Aggarwal, Rafat Ahmed, Mohammad Aslam Frontiers in Psychology, 2023 BackgroundStudy aimed to assess stress in COVID-19 recovered individuals using a validated questionnaire PSS-10 score and stress biomarkers – salivary cortisol and serum copeptin.MethodsA total of 83 subjects of which 54 subjects (66.3%) who were hospitalized were recruited 8–20 weeks following recovery from COVID-19. Stress was assessed by PSS-10 stress-scale after a mean duration of 14.5 weeks after recovery. Sixty-eight subjects (81.9%) had new or persistent symptoms after recovery. Subjects were divided into two groups on the basis of PSS score; mild stress (PSS:0–13) and moderate to severe stress (PSS:>14) and levels of biomarkers (serum copeptin, DHEAS and salivary cortisol) were compared in the two groups.ResultsForty-four subjects (53%) had moderate to severe stress and 39 subjects (47%) had mild stress. Subjects with post COVID symptoms had significantly higher stress levels as compared to subjects who were asymptomatic [15 vs. 9; p = 0.003]. Serum copeptin levels were significantly higher among subjects with moderate to severe stress as compared to those with mild stress [0.41 vs. 0.67 ng/mL; p = 0.031]. Subjects with moderate to severe stress had higher median salivary cortisol compared to subjects with mild stress [1.03 vs. 1.44 nmol/L; p = 0.448].ConclusionOur study demonstrated moderate to severe stress in over half and some level of stress in nearly all COVID recovered individuals even after 3 months. Serum copeptin was found to be a useful biomarker to objectively measure stress in these subjects.
Apparent Treatment - Resistant Hypertension in Hypertensive Stroke Patients Journal International Medical Sciences Academy, 2022
Sars-cov-2 vaccines: A systematic review Journal of the Indian Medical Association, 2021
All in the name of flavour, fragrance & freshness: Commonly used smokeless tobacco preparations in & around a tertiary hospital in India Indian Journal of Medical Research, 2012
Right ventricular endomyocardial fibrosis presenting with ventricular tachycardia and apical thrombus - An interesting presentation Indian Pacing and Electrophysiology Journal, 2009
Response to paper 'malignant ventricular arrhythmias due to aconitum napellus root' Indian Heart Journal, 2008
Acute myocardial infarction associated with carotid and left ventricular atherothrombosis: Clinical and preventive relevance Journal of Internal Medicine of India, 2007